Cordlife

Leading cell therapy company, CyGenics Limited (ASX: CYN), today announced its results for half year from 1 July to 31 December 2005.

Leading cell therapy services company CyGenics Ltd. (ASX: CYN) today announced the appointment of Mr Alberto J. Bautista to its Board of Directors, as a non-executive director.

Leading cell therapy company CyGenics Ltd. (ASX: CYN) announced that it will be part of a new international collaborative effort to develop new treatments for cancer. This will be done via the novel approach of developing and mobilising immune cells outside the human body.

Leading cell therapy company CyGenics Ltd. (ASX: CYN) today announced the formation of CordLife Sciences (India) Private Limited, a cord blood banking company. The new company will open its head office in Kolkata.

CyGenics Ltd (ASX: CYN) today updated the market on its commercialisation plans and financial resources allocation across its four key businesses for 2006 after completing a strategy review with a detailed assessment of the resource allocations and priorities of each subsidiary business.

CyGenics Ltd (ASX: CYN) announced that its wholly-owned subsidiary, Cell Sciences Pte Ltd, has signed an Memorandum of Understanding (MOU) with Rockeby Biomed (ASX: RBY) for logistics, sales, marketing and master distribution of the Avian (bird) and Human Flu Tests for the Singapore, Malaysia, Hong Kong, Indonesia, Myanmar, Cambodia, Philippines and Vietnam markets.

CyGenics Ltd. (ASX: CYN) today announced the appointment of Associate Professor Mark Kirkland as its Chief Scientific Officer, with effect from 1st December 2005.

Leading cell therapy company CyGenics Limited (ASX: CYN) announced today that its wholly-owned subsidiary, Cell Sciences Ltd, has entered into a non-exclusive distribution agreement with CombiMatrix group of Acacia Research Corporation (Nasdaq: CBMX:ACTG), to distribute CombiMatrix products and services in Singapore.

Leading cell therapy company CyGenics Ltd. (ASX: CYN), today announced its intention to investigate the listing of its tissue banking business, predominantly held under its subsidiary, CordLife Pte Ltd, on a key Asian stock exchange.

CyGenics Limited (ASX: CYN) announced today that it has entered into a collaborative research agreement with the Johns Hopkins University School of Medicine (Johns Hopkins), a US world leader in research and education in medicine.